LFMD LifeMD Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LFMD

Price (delayed)

$4.865

Market cap

$235.28M

P/E Ratio

97.3

Dividend/share

N/A

EPS

$0.05

Enterprise value

$206.98M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 59
Relative Valuation: Rel. Valuation: 63
Relative Profitability: Rel. Profitability: 58

LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable ...

Highlights
The debt has dropped by 75% year-on-year and by 2.4% since the previous quarter
The gross profit has grown by 16% from the previous quarter and by 11% YoY
LifeMD's net income has surged by 131% YoY but it has shrunk by 64% QoQ
The EPS has soared by 110% YoY but it has plunged by 80% from the previous quarter
LifeMD's equity has decreased by 35% QoQ
Sector: Healthcare
Industry: Health Information Services
Website: http://lifemd.com
Peers: PHR PHUN

Key stats

What are the main financial stats of LFMD

LFMD stock price

How has the LifeMD stock price performed over time
Intraday
6.69%
1 week
5.99%
1 month
-4.42%
1 year
-60.41%
YTD
42.67%
QTD
34.76%

Financial performance

How have LifeMD's revenue and profit performed over time
Revenue
$219.42M
Gross profit
$192.63M
Operating income
-$12.9M
Net income
$5.21M
Gross margin
87.8%
Net margin
2.4%
LifeMD's net income has surged by 131% YoY but it has shrunk by 64% QoQ
The net margin has surged by 129% year-on-year but it has dropped by 68% since the previous quarter
LFMD's operating income has plunged by 68% from the previous quarter but it is up by 21% YoY
LFMD's operating margin is down by 48% since the previous quarter but it is up by 28% year-on-year

Price vs fundamentals

How does LFMD's price correlate with its fundamentals

Growth

What is LifeMD's growth rate over time

Valuation

What is LifeMD stock price valuation
P/E
97.3
P/B
15.52
P/S
1.05
EV/EBIT
33.18
EV/EBITDA
12.21
EV/Sales
0.94
The EPS has soared by 110% YoY but it has plunged by 80% from the previous quarter
LifeMD's equity has decreased by 35% QoQ
The P/S is 35% below the 5-year quarterly average of 1.5 and 35% below the last 4 quarters average of 1.5
The revenue has grown by 13% from the previous quarter and by 10% YoY

Efficiency

How efficient is LifeMD business performance
The ROS has soared by 141% YoY but it has plunged by 65% from the previous quarter
LFMD's ROA has soared by 111% year-on-year but it has dropped by 81% since the previous quarter
LifeMD's ROE has plunged by 90% from the previous quarter

Dividends

What is LFMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFMD.

Financial health

How did LifeMD financials performed over time
LifeMD's total assets is 27% more than its total liabilities
The current ratio has increased by 27% year-on-year but it has declined by 17% since the previous quarter
LFMD's total liabilities is down by 26% year-on-year but it is up by 17% since the previous quarter
The debt is 59% smaller than the equity
LFMD's debt to equity has surged by 104% year-on-year and by 52% since the previous quarter
The debt has dropped by 75% year-on-year and by 2.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.